Discriminative expression of whole blood genes in HIV patients with latent and active TB in Ethiopia

Tuberculosis

Volumn 100, Issue , 2016, Pages 25-31

  Kassa, Desta ^a,b   Ran, Leonie ^b   Jager, Wilco de ^b   van den Broek, Theo ^b   Jacobi, Ronald ^b   Mekonen, Muluberhan ^a,c   Messele, Tsehaynesh ^a   Haks, Mariëlle C ^d   Ottenhoff, Tom H M ^d   van Baarle, Debbie ^b  

^a ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c AKSUM UNIVERSITY   (Ethiopia)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Biomarker; Host gene; Tuberculosis

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8ALPHA ANTIGEN; CHEMOKINE RECEPTOR CXCR5; FCGR1A PROTEIN; FLICE INHIBITORY PROTEIN; FPR1 PROTEIN; GELATINASE B; INTERLEUKIN 7 RECEPTOR; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PROTEIN; PROTEIN BCL 2; RNA DIRECTED DNA POLYMERASE; SEC14L1 PROTEIN; TIMP2 PROTEIN; TNFRSF1A PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; GENETIC MARKER;

ADULT; ARTICLE; BLOOD; CELL DIFFERENTIATION; CELLULAR IMMUNITY; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHIOPIA; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INNATE IMMUNITY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS; ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL TRIAL; COINFECTION; DIFFERENTIAL DIAGNOSIS; GENETIC MARKER; GENETICS; MIDDLE AGED; MULTICENTER STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; COINFECTION; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION; GENETIC MARKERS; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 84978524162     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2016.06.003     Document Type: Article

References (44)

1. [1] Young, D.B., Perkins, M.D., Duncan, K., Barry, C.E. 3rd, Confronting the scientific obstacles to global control of tuberculosis. J Clin Investig 118 (2008), 1255–1265.
2. [2] Ottenhoff, Tom H.M., Kaufmann, Stefan H.E., Vaccines against tuberculosis: where are we and where do we need to go?. PLoS Pathog, 8(5), 2012 May, e1002607.
3. [3] Colditz, G., Brewer, T., Berkey, C., Wilson, M., Burdick, E., Fienberg, H., Mosteller, F., Efficacy of BCG vaccine in the prevention of tuberculosis. Met-analyisi of the published literature. JAMA 271 (1994), 698–702.
4. [4] O'Garra, A., Redford, P.S., McNab, F.W., Bloom, C.I., Wilkinson, R.J., Berry, M.P., The immune response in tuberculosis. Annu Rev Immunol 31 (2013), 475–527.
5. [5] Wallis, R.S., Pai, M., Menzies, D., Biomarkers and diagnostics for tuberculosis: progress, needs and translation in to practice. Lancet 375 (2010), 1920–1937.
6. [6] Gerhard W, Katharina R, Willem H, Thomas JS, and Alimuddin Z. Immunological biomarkers of tuberculosis. Natur Rev Immunol. 200; 11: 343–354.
7. [7] Engwegen, J.Y., Helgason, H.H., Cats, A., Harris, N., Bonfrer, J.M., Schellens, J.H., Beijnen, J.H., Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. World J Gastroenterol 12:10 (2006), 1536–1544.
8. [8] Jacobsen, M., Repsilber, D., Gutschmidt, A., Neher, A., Feldmann, K., Mollenkopf, H.J., Ziegler, A., Kaufmann, S.H., Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85 (2007), 613–621.
9. [9] Maertzdorf, J., Repsilber, D., Parida, S.K., Stanley, K., Roberts, T., Black, G., Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12 (2011), 15–22.
10. [10] Joosten, S.A., Goeman, J.J., Sutherland, J.S., Opmeer, L., de Boer, K.G., Jacobsen, M., Kaufmann, S.H., Finos, L., Magis-Escurra, C., Ota, M.O., Ottenhoff, T.H., Haks, M.C., Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay. Genes Immun 13 (2012), 71–82.
11. [11] Berry, M.P., Graham, C.M., McNab, F.W., Xu, Z., Bloch, S.A., Oni, T., Wilkinson, K.A., Banchereau, R., Skinner, J., Wilkinson, R.J., Quinn, C., Blankenship, D., Dhawan, R., Cush, J.J., Mejias, A., Ramilo, O., Kon, O.M., Pascual, V., Banchereau, J., Chaussabel, D., O'Garra, A., An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:7309 (2010 Aug 19), 973–977.
12. [12] Gagneux, S., Small, P.M., Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. Lancet Infect Dis 7:5 (2007), 328–337.
13. [13] Van Crevel, R., Ottenhoff, T.H.M., Van der Meer, W.M., Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15 (2009), 294–309.
14. [14] Ottenhoff, H.M., Jerrold, J., Ellner, B., Kaufmann, S.H., Ten challenges for TB biomarkers. Tuberculosis 92S1 (2012), S17–S20.
15. [15] Doherty, T.M., Wallis, R.S., Zumla, A., Biomarkers of disease activity, cure, and relapse in tuberculosis. Clin Chest Med, 2009, 783–796.
16. [16] Walzl, G., Ronacher, K., Hanekom, W., Scriba, T.J., Zumla, A., Immunological biomarkers of tuberculosis. Nat Rev Immunol 11:5 (2011), 343–354.
17. [17] Sutherland, J.S., Lalor, M.K., Black, G.F., Ambrose, L.R., Loxton, A.G., Chegou, N.N., Kassa, D., Mihret, A., Howe, R., Mayanja-Kizza, H., Gomez, M.P., Donkor, S., Franken, K., Hanekom, W., Klein, M.R., Parida, S.K., Boom, W.H., Thiel, B.A., Crampin, A.C., Ota, M., Walzl, G., Ottenhoff, T.H., Dockrell, H.M., Kaufmann, S.H., GCGH Biomarkers for TB consortium, Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa. PLoS One, 8(9), 2013, e74080.
18. [18] Federal Ministry of Hearlth (FMOH), Guidline for clinical and programatic managment of TB, TB/HIV and Leprosy in Ethiopia. 5th ed., March, 2013.
19. [19] Flynn, J., Immunology of tuberculosis and implications in vaccine development. Tuberculosis 4 (2004), 93–101.
20. [20] Zuniga, J., Torees-Garicia, D., Santos-Mendoza, T., Rodriguez-Reyna, T., Granados, J., Yunis, E.J., Cellular and humoral mechanisms involved in the control of tuberculosis. Clin Dev Immunol, 2012, 2012, 193923.
21. [21] Bonecini-Almeida, M.G., Ho, J.L., Boechat, N., Huard, R.C., Chitale, S., Doo, H., Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 72 (2004), 2628–2634.
22. [22] Buijtels, P.C., van de Sande, W.W., Parkinson, S., Petit, P.L., van der Sande, M.A., Van, S.D., Verbrugh, H.A., van, B.A., Polymorphism in CC-chemokine ligand 2 associated with tuberculosis in Zambia. Int J Tuberc Lung Dis 12 (2008), 1485–1488.
23. [23] Moller, M., Nebel, A., Valentonyte, R., van Helden, P.D., Schreiber, S., Hoal EG Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberc 89 (2009), 189–194 (Edinb).
24. [24] Cliff, J.M., Lee, J.S., Constantinou, N., Cho, J.E., Clark, T.G., Ronacher, K., King, E.C., Lukey, P.T., Duncan, K., Van Helden, P.D., Walzl, G., Dockrell, H.M., Distinct phases of blood gene expression pattern through tuberculosis treatment reflect modulation of the humoral immune response. J Infect Dis 207:1 (2013), 18–29.
25. [25] Oh, M.D., Park, S.W., Kim, H.B., Spectrum of opportunistic infections and malignancies in patients with human immunodeficiency virus infection in South Korea. Clin Infect Dis 29 (1999), 1524–1528.
26. [26] Siawaya, D., Ruhwald, M., Eugen-Olsen, J., Walzl, G., Correlates for disease progression and prognosis during concurrent HIV/TB infection: review. Int J Infect Dis 11:4 (2007), 289–299 2007.
27. [27] Olivares, N., Puig, A., Aguilar, D., Moya, A., Cádiz, A., Otero, O., Izquierdo, L., Falero, G., Solis, R.L., Orozco, H., Sarmiento, M.E., Norazmi, M.N., Hernández-Pando, R., Acosta, A., Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis. Tuberculosis 89:3 (2009), 218–220.
28. [28] Maglione, P.J., Xu, J., Casadevall, A., Chan, J., Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. J Immunol 180:5 (2008), 3329–3338.
29. [29] Guilliams, M., Bruhns, P., Saeys, Y., Hammad, H., Lambrecht, B.N., The function of Fcγ receptors in dendritic cells and macrophages. Nat Rev Immunol 14:2 (2014), 94–108.
30. [30] Sheen, P., O'Kane, C.M., Chaudhary, K., Tovar, M., Santillan, C., Sosa, J., Caviedes, L., High MMP9 activity characterises pleural tuberculosis correlating with granuloma formation. Eur Respir J 33 (2009), 134–141.
31. [31] Price, N.M., Farrar, J., Tran, T.T., Nguyen, T.H., Tran, T.H., Friedland, J.S., Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo. J Immunol 166 (2001), 4223–4230.
32. [32] De Groote, M.A., Nahid, P., Jarlsberg, L., Johnson, J.L., Weiner, M., Muzanyi, G., Janjic, N., Sterling, D.G., Ochsner, U.A., Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment. PLoS One, 8(4), 2013, e61002.
33. [33] Taylor, J.L., Hattle, J.M., Dreitz, S.A., Troudt, J.M., Izzo, L.S., Basaraba, R.J., Orme, I.M., Matrisian, L.M., Izzo, A.A., Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect Immun 74:11 (2006), 6135–6144.
34. [34] Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., Gray, P.W., Matsushima, K., Yoshie, O., Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol 11:1 (1999), 81–88.
35. [35] Remus, N., El, B.J., Fieschi, C., Feinberg, J., Quintin, T., Chentoufi, M., Schurr, E., Benslimane, A., Casanova, J.L., Abel, L., Association of IL12RB1 polymorphisms with pulmonary tuberculosis in adults in Morocco. J Infect Dis 190 (2004), 580–587.
36. [36] Boer, M.C., Joosten, S.A., Ottenhoff, T.H., Regulatory t-cells at the interface between human host and pathogens in infectious diseases and vaccination. Front Immunol, 6, 2015, 217.
37. [37] Rodrigues, M.F., Alves, C.C., Figueiredo, B.B., Rezende, A.B., Wohlres-Viana, S., Silva, V.L., Machado, M.A., Teixeira, H.C., Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis. Immunology 139:4 (2013), 503–512.
38. [38] Cooke, G.S., Campbell, S.J., Sillah, J., Gustafson, P., Bah, B., Sirugo, G., Bennett, S., McAdam, K.P., Sow, O., Lienhardt, C., Hill, A.V., Polymorphism within the interferon-gamma/receptor complex is associated with pulmonary tuberculosis. Am J Respir Crit Care Med 174 (2006), 339–343.
39. [39] Placido, R., Mancino, G., Amendola, A., Mariani, F., Vendetti, S., Piacentini, M., Sanduzzi, A., Bocchino, M.L., Zembala, M., Colizzi, V., Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J Pathol 181 (1997), 31–38.
40. [40] Behar, S.M., Martin, C.J., Booty, M.G., Nishimura, T., Zhao, X., Gan, H.X., Divangahi, M., Remold, H.G., Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol 4:3 (2011), 279–287.
41. [41] Wu, C., Zhou, Q., Qin, X.J., Qin, S.M., Shi, H.Z., CCL22 is involved in the recruitment of CD4+CD25 high T cells into tuberculous pleural effusions. Respirology 15:3 (2010), 522–529.
42. [42] Galli, G., Chantry, D., Annunziato, F., Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. Eur J Immunol 30 (2000), 204–210.
43. [43] Khader, S.A., Rangel-Moreno, J., Fountain, J.J., Martino, C.A., Reiley, W.W., Pearl, J.E., Winslow, G.M., Woodland, D.L., Randall, T.D., Cooper, A.M., In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity. J Immunol 183:12 (2009), 8004–8014.
44. [44] Kaufmann, S.H.E., Parida, S.K., Tuberculosis in Africa: learning from pathogenesis for biomarker identification. Cell Host Microbe 4:3 (2008), 219–228.